Trump Executive Order Reschedules Cannabis to Schedule III, Expands Medicare CBD Access

President Donald Trump signed a significant executive order on December 18, 2025. This order makes major changes to federal cannabis policy. It directs the Justice Department to expedite marijuana’s rescheduling. Marijuana moves from Schedule I to Schedule III of the Controlled Substances Act. This is a historic shift. It eases restrictions on medical research. It…

Read More

Trump Considers Cannabis Rescheduling Amidst Broader Policy Shifts

President Trump Signals Potential Federal Rescheduling of Cannabis President Donald Trump is reportedly considering a significant policy shift. He indicated his administration is “very strongly” looking at reclassifying marijuana. This would move it from Schedule I to Schedule III under the Controlled Substances Act. This announcement came during a signing ceremony. It adds momentum to…

Read More

Alabama Approves Medical Marijuana Dispensary Licenses for 2026 Launch

Alabama Takes Major Step Towards Medical Cannabis Sales The Alabama Medical Cannabis Commission (AMCC) has officially approved dispensary licenses. This marks a crucial milestone. The state’s medical marijuana program is now on track for a 2026 start. Patients could see legal cannabis products by spring 2026. This news comes after years of significant delays. Litigation…

Read More

Trump Administration Eyes Rescheduling Marijuana: A Potential Win for Research and Industry

President Trump is seriously considering a major policy shift. His administration is weighing a plan to ease federal restrictions on marijuana. The White House is exploring reclassifying cannabis. This move would change its federal drug classification. It is currently listed as a Schedule I substance. This classification implies high abuse potential. It also states no…

Read More